Cargando…

Ndel1 modulates dynein activation in two distinct ways

Dynein is the primary minus-end-directed microtubule motor [1]. To achieve activation, dynein binds to the dynactin complex and an adaptor to form the “activated dynein complex” [2, 3]. The protein Lis1 aids activation by binding to dynein and promoting its association with dynactin and adaptor [4,...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrott, Sharon R, Gillies, John P, Siva, Aravintha, Little, Saffron R, Jbeily, Rita EI, DeSantis, Morgan E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900795/
https://www.ncbi.nlm.nih.gov/pubmed/36747695
http://dx.doi.org/10.1101/2023.01.25.525437
_version_ 1784882919414693888
author Garrott, Sharon R
Gillies, John P
Siva, Aravintha
Little, Saffron R
Jbeily, Rita EI
DeSantis, Morgan E
author_facet Garrott, Sharon R
Gillies, John P
Siva, Aravintha
Little, Saffron R
Jbeily, Rita EI
DeSantis, Morgan E
author_sort Garrott, Sharon R
collection PubMed
description Dynein is the primary minus-end-directed microtubule motor [1]. To achieve activation, dynein binds to the dynactin complex and an adaptor to form the “activated dynein complex” [2, 3]. The protein Lis1 aids activation by binding to dynein and promoting its association with dynactin and adaptor [4, 5]. Ndel1 and its orthologue Nde1 are dynein and Lis1 binding proteins that help control where dynein localizes within the cell [6]. Cell-based assays suggest that Ndel1/Nde1 also work with Lis1 to promote dynein activation, although the underlying mechanism is unclear [6]. Using purified proteins and quantitative binding assays, we found that Ndel1’s C-terminal region contributes to binding to dynein and negatively regulates binding to Lis1. Using single-molecule imaging and protein biochemistry, we observed that Ndel1 inhibits dynein activation in two distinct ways. First, Ndel1 disfavors the formation of the activated dynein complex. We found that phosphomimetic mutations in Ndel1’s C-terminal domain increase its ability to inhibit dynein-dynactin-adaptor complex formation. Second, we observed that Ndel1 interacts with dynein and Lis1 simultaneously and sequesters Lis1 away from its dynein binding site. In doing this, Ndel1 prevents Lis1-mediated dynein activation. Our work suggests that in vitro, Ndel1 is a negative regulator of dynein activation, which contrasts with cellular studies where Ndel1 promotes dynein activity. To reconcile our findings with previous work, we posit that Ndel1 functions to scaffold dynein and Lis1 together while keeping dynein in an inhibited state. We speculate that Ndel1 release can be triggered in cellular settings to allow for timed dynein activation.
format Online
Article
Text
id pubmed-9900795
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-99007952023-02-07 Ndel1 modulates dynein activation in two distinct ways Garrott, Sharon R Gillies, John P Siva, Aravintha Little, Saffron R Jbeily, Rita EI DeSantis, Morgan E bioRxiv Article Dynein is the primary minus-end-directed microtubule motor [1]. To achieve activation, dynein binds to the dynactin complex and an adaptor to form the “activated dynein complex” [2, 3]. The protein Lis1 aids activation by binding to dynein and promoting its association with dynactin and adaptor [4, 5]. Ndel1 and its orthologue Nde1 are dynein and Lis1 binding proteins that help control where dynein localizes within the cell [6]. Cell-based assays suggest that Ndel1/Nde1 also work with Lis1 to promote dynein activation, although the underlying mechanism is unclear [6]. Using purified proteins and quantitative binding assays, we found that Ndel1’s C-terminal region contributes to binding to dynein and negatively regulates binding to Lis1. Using single-molecule imaging and protein biochemistry, we observed that Ndel1 inhibits dynein activation in two distinct ways. First, Ndel1 disfavors the formation of the activated dynein complex. We found that phosphomimetic mutations in Ndel1’s C-terminal domain increase its ability to inhibit dynein-dynactin-adaptor complex formation. Second, we observed that Ndel1 interacts with dynein and Lis1 simultaneously and sequesters Lis1 away from its dynein binding site. In doing this, Ndel1 prevents Lis1-mediated dynein activation. Our work suggests that in vitro, Ndel1 is a negative regulator of dynein activation, which contrasts with cellular studies where Ndel1 promotes dynein activity. To reconcile our findings with previous work, we posit that Ndel1 functions to scaffold dynein and Lis1 together while keeping dynein in an inhibited state. We speculate that Ndel1 release can be triggered in cellular settings to allow for timed dynein activation. Cold Spring Harbor Laboratory 2023-01-25 /pmc/articles/PMC9900795/ /pubmed/36747695 http://dx.doi.org/10.1101/2023.01.25.525437 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Garrott, Sharon R
Gillies, John P
Siva, Aravintha
Little, Saffron R
Jbeily, Rita EI
DeSantis, Morgan E
Ndel1 modulates dynein activation in two distinct ways
title Ndel1 modulates dynein activation in two distinct ways
title_full Ndel1 modulates dynein activation in two distinct ways
title_fullStr Ndel1 modulates dynein activation in two distinct ways
title_full_unstemmed Ndel1 modulates dynein activation in two distinct ways
title_short Ndel1 modulates dynein activation in two distinct ways
title_sort ndel1 modulates dynein activation in two distinct ways
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900795/
https://www.ncbi.nlm.nih.gov/pubmed/36747695
http://dx.doi.org/10.1101/2023.01.25.525437
work_keys_str_mv AT garrottsharonr ndel1modulatesdyneinactivationintwodistinctways
AT gilliesjohnp ndel1modulatesdyneinactivationintwodistinctways
AT sivaaravintha ndel1modulatesdyneinactivationintwodistinctways
AT littlesaffronr ndel1modulatesdyneinactivationintwodistinctways
AT jbeilyritaei ndel1modulatesdyneinactivationintwodistinctways
AT desantismorgane ndel1modulatesdyneinactivationintwodistinctways